124 related articles for article (PubMed ID: 23581013)
1. Cancer as a metabolic disease and diabetes as a cancer risk?
Kankova K; Hrstka R
Klin Onkol; 2012; 25 Suppl 2():2S26-31. PubMed ID: 23581013
[TBL] [Abstract][Full Text] [Related]
2. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
Levine AJ; Puzio-Kuter AM
Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
[TBL] [Abstract][Full Text] [Related]
3. miRNAs link metabolic reprogramming to oncogenesis.
Hatziapostolou M; Polytarchou C; Iliopoulos D
Trends Endocrinol Metab; 2013 Jul; 24(7):361-73. PubMed ID: 23602813
[TBL] [Abstract][Full Text] [Related]
4. Post-translational modifications and the Warburg effect.
Hitosugi T; Chen J
Oncogene; 2014 Aug; 33(34):4279-85. PubMed ID: 24096483
[TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism in cancer cells.
Annibaldi A; Widmann C
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):466-70. PubMed ID: 20473153
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
Daye D; Wellen KE
Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
[TBL] [Abstract][Full Text] [Related]
7. Glucose avidity of carcinomas.
Ortega AD; Sánchez-Aragó M; Giner-Sánchez D; Sánchez-Cenizo L; Willers I; Cuezva JM
Cancer Lett; 2009 Apr; 276(2):125-35. PubMed ID: 18790562
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and cancer: an overview.
Sosa V; Moliné T; Somoza R; Paciucci R; Kondoh H; LLeonart ME
Ageing Res Rev; 2013 Jan; 12(1):376-90. PubMed ID: 23123177
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
10. Oncogenes and suppressor genes: their involvement in colon cancer.
Rigas B
J Clin Gastroenterol; 1990 Oct; 12(5):494-9. PubMed ID: 2229991
[TBL] [Abstract][Full Text] [Related]
11. [Oncogenes--"reckless drivers" on signal pathways controlling cell division].
Johansen T; Bjørkøy G
Tidsskr Nor Laegeforen; 1998 May; 118(12):1880-5. PubMed ID: 9638058
[TBL] [Abstract][Full Text] [Related]
12. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming.
Eng CH; Abraham RT
Oncogene; 2011 Nov; 30(47):4687-96. PubMed ID: 21666712
[TBL] [Abstract][Full Text] [Related]
13. The Warburg effect and its cancer therapeutic implications.
Chen Z; Lu W; Garcia-Prieto C; Huang P
J Bioenerg Biomembr; 2007 Jun; 39(3):267-74. PubMed ID: 17551814
[TBL] [Abstract][Full Text] [Related]
14. The Warburg effect in 2012.
Bayley JP; Devilee P
Curr Opin Oncol; 2012 Jan; 24(1):62-7. PubMed ID: 22123234
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and cancer.
Zelenko Z; Gallagher EJ
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):167-85. PubMed ID: 24582097
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy.
Scatena R; Bottoni P; Pontoglio A; Giardina B
Proteomics Clin Appl; 2010 Feb; 4(2):143-58. PubMed ID: 21137040
[TBL] [Abstract][Full Text] [Related]
17. Links between metabolism and cancer.
Dang CV
Genes Dev; 2012 May; 26(9):877-90. PubMed ID: 22549953
[TBL] [Abstract][Full Text] [Related]
18. Cancer research. Unraveling the obesity-cancer connection.
Taubes G
Science; 2012 Jan; 335(6064):28, 30-2. PubMed ID: 22223787
[No Abstract] [Full Text] [Related]
19. Tumor suppressors and cell metabolism: a recipe for cancer growth.
Jones RG; Thompson CB
Genes Dev; 2009 Mar; 23(5):537-48. PubMed ID: 19270154
[TBL] [Abstract][Full Text] [Related]
20. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology.
Acker T; Plate KH
J Mol Med (Berl); 2002 Sep; 80(9):562-75. PubMed ID: 12226738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
